Skip to main content

Table 1 Demographic characteristics and clinical data of the patients

From: A nomogram to predict left atrial appendage thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients

Variables

SEC/LAAT group

(n = 223)

SEC/LAAT-free group

(n = 164)

P value

Demographics

   

Age (years), median (IQR)

66 (60, 71)

65 (58, 69)

0.06

Age < 65

94 (42.2)

81 (49.4)

 

65 ≤ Age < 75 (%)

105 (47.1)

69 (42.1)

 

Age ≥ 75 (%)

24 (10.8)

14 (8.5)

 

Gender (male, %)

100 (44.8)

98 (59.8)

0.37

BMI (kg/m2, mean ± SD)

25.0 ± 4.1

25.2 ± 3.1

0.73

Medical history

   

Smoking (%)

21 (9.4)

19 (11.6)

0.72

Drinking (%)

38 (17.0)

26 (18.8)

0.10

Non-Paroxysmal AF (%)

168 (75.3)

50 (30.5)

 < 0.05

Anticoagulants (%)

103 (46.2)

62 (37.8)

0.08

Warfarin (%)

21 (9.4)

13 (7.9)

 

Rivaroxaban (%)

36 (16.1)

22 (13.4)

 

Dabigatran (%)

46 (20.6)

29 (17.7)

 

Comorbidities

   

Congestive heart failure (%)

29 (13.0)

4 (2.4)

 < 0.05

Hypertension (%)

142 (63.7)

92 (56.1)

0.13

Diabetes mellitus (%)

33 (14.8)

19 (11.6)

0.36

TIA/Stroke/embolism (%)

21 (9.4)

9 (5.5)

0.15

Vascular disease (%)

18 (8.1)

16 (9.8)

0.56

Predictive models, median (IQR)

   

CHA2DS2 score

2 (1, 3)

2 (1, 3)

0.01

CHA2DS2-VASc score

2 (1, 3)

2 (1, 3)

0.01

0 (%)

20 (9.0)

73 (44.5)

 

1 (%)

57 (25.6)

24 (14.6)

 

2 (%)

53 (23.8)

49 (29.9)

 

 ≥ 3 (%)

93 (41.7)

18 (11.0)

 

ATRIA score

4 (1, 5)

3 (1, 5)

0.01

Laboratory test, median (IQR)

   

Platelet (109/l)

175.8 ± 53.1

185.4 ± 55.4

0.09

WBC (109/l)

5.8 (4.6, 6.7)

5.5 (4.7, 6.7)

0.66

Hemoglobin (g/l)

141.0 (128.0, 152.0)

140.0 (128.0, 151.0)

0.64

NT-proBNP (pg/ml)

734.2 (313.0, 1447.0)

201.2 (72.7, 462.4)

 < 0.05

Positive urine protein (%)

2 (0.9)

4 (2.4)

0.42

Creatinine (umol/L)

68.9 (58.8, 82.5)

67.7 (57.8, 76.5)

0.17

hs-CRP (mg/l)

1.5 (0.7, 3.4)

1.2 (0.6, 2.7)

0.15

ALB (g/l)

38.7 (36.9, 41.3)

40.3 (38.2, 43.0)

 < 0.05

D-dimer

0.22 (0.15, 0.35)

0.22 (0.16, 0.35)

0.33

Echocardiography, median (IQR)

   

LAD (mm)

46.0 (43.0, 51.0)

42.0 (39.0, 45.0)

 < 0.05

RAD (mm)

41.0 (37.0, 46.0)

37.0 (35.0, 40.0)

 < 0.05

IVSth (mm)

9.0 (9.0, 10.0)

9.0 (9.0, 10.0)

0.58

LVDD (mm)

50.0 (47.0, 53.0)

49.0 (46.0, 52.0)

0.02

LVEF (%)

60.0 (55.0, 63.0)

62.0 (59.0, 65.8)

 < 0.05

EDT (ms)

180.0 (148.0, 211.0)

191.5 (157.0, 232.0)

0.01

LAA function, median (IQR)

   

LAAEV (cm/s)

29.0 (22.0, 42.0)

54.5 (40.0, 71.0)

 < 0.05

LAAFV (cm/s)

37.0 (26.0, 51.0)

51.0 (38.0, 67.5)

 < 0.05

LAAEF (%)

41.0 (28.0, 59.0)

87.5 (65.3, 95.0)

 < 0.05

LAAD (mm)

20.0 (17.0, 23.0)

18.0 (16.0, 21.0)

 < 0.05

LAAGPLS

8.9 (6.1, 12.3)

16.6 (13.1, 22.75)

 < 0.05

  1. BMI, body mass index; WBC, white blood cell; NT-proBNP, N-terminal pro-B-type natriuretic peptide; hs-CRP, hypersensitive C-reactive protein; ALB, albumin; LAD, left atrial diameter; RAD, right atrial diameter; IVSth, interventricular septum thickness; LVDD, left ventricle end-diastolic diameter; LVEF, left ventricular ejection fraction; EDT, E-wave deceleration time; LAAEV, left atrial appendage emptying velocity; LAAFV, left atrial appendage filling velocity; LAAEF, left atrial appendage ejection fraction; LAAD, left atrial appendage diameter; LAAGPLS, left atrial appendage global peak longitudinal strain